Skip to main content
. 2021 Feb 9;9(2):e001945. doi: 10.1136/jitc-2020-001945

Table 3.

Treatment related adverse events

Grade 1–2 Grade 3–4 Grade 5 Total
Any TRAE, patients (%) 13 (52%)
Adverse events, n (%)
 Skin related 7 (28%) 0 1 (4%) 8 (32%)
 Hepatitis 0 1 (4%) 0 1 (4%)
 Colitis 1 (4%) 1 (4%) 0 2 (8%)
 Hypothyroidism/adrenal insufficiency 5 (20%) 0 0 5 (20%)
 Constitutional 2 (8%) 0 0 2 (8%)

TRAE, treatment-related adverse event.